Bharat Parenterals Ltd - 541096 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- LUBHANSHI JHALANIDesignation :- Company Secretary and Compliance Officer Bharat Parenterals Ltd - 541096 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we bring to your kind attention that the Company/RTA has issued duplicate Share certificates Bharat Parenterals Ltd - 541096 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we bring to your kind attention that the Company/RTA has issued duplicate Share certificatesPursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we bring to your kind attention that the Company/RTA has issued duplicate Share certificates Bharat Parenterals Ltd - 541096 - Financial Results For The Quarter Ended December 31, 2021
In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 09th February, 2022 has considered and approved the Unaudited Financial Results for the Quarter ended 31st December, 2021 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. In this respect, we hereby enclose following: 1. Unaudited Financial Results for the Quarter ended 31st December, 2021. 2. Limited Review Report on the said Financial Results. The meeting of Board of Directors commenced at 01.30 p.m. and concluded at 02:00 p.m. Request you to please take the same on record. Bharat Parenterals Ltd - 541096 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 09.02.2022
In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 09th February, 2022 has considered and approved the Unaudited Financial Results for the Quarter ended 31st December, 2021 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. In this respect, we hereby enclose following: 1. Unaudited Financial Results for the Quarter ended 31st December, 2021. 2. Limited Review Report on the said Financial Results. The meeting of Board of Directors commenced at 01.30 p.m. and concluded at 02:00 p.m. Request you to please take the same on record. Bharat Parenterals Ltd - 541096 - Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors For Approval Of Unaudited Financial Results For The Quarter Ended 31St December, 2021.
Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2022 ,inter alia, to consider and approve The unaudited financial results of the Company for the Quarter ended on December 31, 2021. Bharat Parenterals Ltd - 541096 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we bring to your kind attention that the Company/RTA has received a request from the shareholder regarding loss of his/her Share certificates. Bharat Parenterals Ltd - 541096 - Shareholding for the Period Ended December 31, 2021
Bharat Parenterals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here Bharat Parenterals Ltd - 541096 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith the Confirmation Certificate pursuant to provisions of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 duly sent and confirmed by Adroit Corporate Services Private Limited viz., Company's Registrar and Share Transfer Agent, registered with Securities and Exchange Board of India for the period ended on 31st December,2021. We request you to kindly take the same on record Bharat Parenterals Ltd - 541096 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- LUBHANSHI JHALANIDesignation :- Company Secretary and Compliance Officer